-

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025

Improving the World of Dietary Supplements with a Breadth of Proven Brands.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cutting-edge dietary supplement plant-based ingredients portfolio of innovative and trusted brands including SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™ in hall 4 at booth 4F25, May 20-22, at the Fira Barcelona Gran Via.

"We are excited to highlight vivid examples of how our high-quality functional ingredients and technical expertise help our customers produce superior supplements," said Firat Nalbantoglu, EMEA commercial leader, IFF Pharma Solutions. "Our technical and commercial experts look forward to offering solutions for formulation and processing challenges. If you aim to enhance efficacy and bioavailability in your dietary supplements, we invite you to discover new possibilities with us."

IFF Pharma Solutions is committed to advancing the dietary supplement industry with its portfolio of high-performance ingredients, offering plant-based solutions and vegan alternatives, as well as reliable technologies for immediate and controlled release:

  • SeaGel® and VERDIGEL™ SC: These plant-based alternatives to gelatin offer clean-label, non-GMO solutions for superior quality and high performance vegan softgels.
  • GRINDSTED® Pectin Premium: A renowned, citrus-sourced ingredient for plant-based gummies that delivers an excellent consumer experience.
  • Avicel®: A cellulose-based tablet binder and filler, Avicel® ensures the production of small, high-quality tablets with low-dusting and efficient tableting processes. Avicel® acts as a suspending agent, enhancing the stability and efficacy of liquid formulations.
  • Ac-Di-Sol®: A non-GMO cellulose-based tablet disintegrant that delivers nutritional ingredients faster.
  • METHOCEL™: A versatile cellulose-based solution for vegetarian hard capsules and controlled-release tablet matrices – resistant to heat and humidity conditions.
  • Accelerate®: A cellulose-based super disintegrant for immediate release.

Visit here to learn more about IFF Pharma Solutions.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contacts

Britta Meys
Global Communications Lead EMEA
+49 151 14486359
britta.meys@iff.com

International Flavors & Fragrances

NYSE:IFF

Release Versions

Contacts

Britta Meys
Global Communications Lead EMEA
+49 151 14486359
britta.meys@iff.com

More News From International Flavors & Fragrances

IFF Report Finds GLP-1 Is Reshaping Food Choices and Eating Behaviors Among Indian Consumers

NEW DELHI--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — released new research examining how GLP-1 use is influencing food behaviors among Indian consumers and what those shifts may mean for the future of food and beverage innovation. The study is the latest in IFF’s GLP-1 global consumer insights following the company’s 2025 GLP-1 Consumer Opportunity Outlook. “We are seeing that a change in appetite can lead to a broader change in the r...

IFF to Webcast Fireside Chat at Barclays Global Consumer Conference on Sept. 10

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that Chief Executive Officer Erik Fyrwald will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, Sept. 10, 2026 at 945 a.m. ET. Investors may access the live webcast on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the gl...

IFF Reports Second Quarter 2026 Results; Announces Use of Proceeds Plan for Food Ingredients Divestiture

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) reported financial results for the second quarter ended June 30, 2026. Results are presented on a continuing operations basis, excluding the Food Ingredients business and other minor perimeter adjustments (the “Food Ingredients disposal group”), and the Soy Crush, Concentrates, and Lecithin businesses (the “SCL disposal group”). The Food Ingredients disposal group and the SCL disposal group are reported as discontinued operations. Second Quarter 2026 C...
Back to Newsroom